D-0389-2019 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0389-2019 was initiated by Dr. Reddy's Laboratories, Inc. on Jan 15, 2019 and is designated Class II. Reason for recall: Presence of Foreign Substance: Product complaint of black speckles observed on tablets. The recall status is terminated (terminated Mar 3, 2020). Affected quantity: 118 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 30, 2019
Initiation Date
Jan 15, 2019
Termination Date
Mar 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
118 bottles

Product description

Ezetimibe and Simvastatin Tablets 10mg/80 mg, 1000-count bottles, Rx only, Manufactured by: Teva Pharmaceuticals Ind. Ltd. Jerusalem, 9777402, Israel; Distributed by: Dr. Reddy's Laboratories Inc. Princeton, NJ 08540 USA, NDC 43598-586-10

Reason for recall

Presence of Foreign Substance: Product complaint of black speckles observed on tablets.

Distribution pattern

Nationwide within the United States

Code information

Lot #: 43E021 and 43E023, Exp. 01/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0389-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0389-2019. Report a data issue: hello@regdatalab.com.